Germany · Delayed Price · Currency is EUR InspireMD Company Description
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific.
The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions.
It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions.
The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.
| Country | United States |
| Founded | 2005 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 86 |
| CEO | Marvin Slosman |
Contact Details
Address: 6303 Waterford District Drive Miami, Delaware 33126 United States | |
| Phone | 888 776 6804 |
| Website | inspiremd.com |
Stock Details
| Ticker Symbol | II2 |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Marvin Slosman | Chief Executive Officer |
| Michael Lawless | Chief Financial Officer |
| Andrea Tommasoli | Chief Operating Officer |